Revvity (RVTY) Depreciation & Amortization (CF) (2009 - 2026)
Revvity's (RVTY) quarterly Depreciation & Amortization (CF) came in at $102.0 million in Q3 2026, down 0.72% on a YoY basis from $102.8 million in Q3 2025, and down 2.87% quarter-over-quarter from $105.1 million in Q2 2026.
Analysis
Revvity (RVTY) Depreciation & Amortization (CF) (2009 - 2026) Analysis & Trends
Revvity (RVTY) has reported Depreciation & Amortization (CF) for 18 consecutive years, with $102.0 million the latest figure, recorded in Q3 2026.
- For the quarter ending Q3 2026, Depreciation & Amortization (CF) fell 0.72% year-over-year to $102.0 million; the trailing twelve-month figure through Jul 2026 stood at $412.2 million (changed 0.16% YoY), and the FY2025 full-year result was $405.3 million, down 5.26% from the prior year.
- Depreciation & Amortization (CF) declined to $102.0 million in Q3 2026 per RVTY's latest filing, from $105.1 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $229.6 million in Q1 2023 and bottomed at $97.4 million in Q1 2025.
- Historically, Depreciation & Amortization (CF) has averaged $113.2 million across 5 years, with a median of $106.5 million in 2023.
- The sharpest annual moves came in 2022 and 2023: Depreciation & Amortization (CF) jumped 55.77% in 2022, then tumbled 54.02% in 2023.
- Over 5 years, Depreciation & Amortization (CF) stood at $109.3 million in 2022, then declined by 3.44% to $105.6 million in 2023, then dropped by 0.51% to $105.0 million in 2024, then fell by 1.86% to $103.1 million in 2025, then fell by 1.01% to $102.0 million in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $102.0 million, $105.1 million, and $103.1 million for Q3 2026, Q2 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 241.68 Bn | 237.61 Bn | 8.34 Bn | - |
| 2 | Danaher | 147.34 Bn | 142.99 Bn | 3.61 Bn | - |
| 3 | Agilent Technologies | 43.34 Bn | 41.59 Bn | 1.04 Bn | 66.00 Mn |
| 4 | Illumina | 34.58 Bn | 33.41 Bn | 770.00 Mn | - |
| 5 | Revvity | 16.31 Bn | 15.29 Bn | 416.87 Mn | 102.04 Mn |
| 6 | Bio-Techne | 11.28 Bn | 11.01 Bn | 211.39 Mn | 24.14 Mn |
| 7 | Bio-Rad Laboratories | 10.16 Bn | 8.54 Bn | 345.80 Mn | - |
| 8 | Repligen | 9.77 Bn | 8.75 Bn | 110.04 Mn | 19.06 Mn |
| 9 | 10x Genomics | 9.45 Bn | 8.90 Bn | 112.50 Mn | 9.66 Mn |
| 10 | Bruker | 9.26 Bn | 9.04 Bn | 416.00 Mn | 58.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 5, 2026 | 102.04 Mn |
| Apr 5, 2026 | 105.06 Mn |
| Dec 28, 2025 | 103.08 Mn |
| Sep 28, 2025 | 102.06 Mn |
| Jun 29, 2025 | 102.78 Mn |
| Mar 30, 2025 | 97.42 Mn |
| Dec 29, 2024 | 105.03 Mn |
| Sep 29, 2024 | 107.67 Mn |
| Jun 30, 2024 | 107.34 Mn |
| Mar 31, 2024 | 107.80 Mn |
| Dec 31, 2023 | 105.57 Mn |
| Oct 1, 2023 | 108.26 Mn |
| Jul 2, 2023 | 108.93 Mn |
| Apr 2, 2023 | 109.01 Mn |
| Jan 1, 2023 | 229.61 Mn |
| Apr 3, 2022 | 109.33 Mn |
| Oct 3, 2021 | 51.56 Mn |
| Jul 4, 2021 | 75.64 Mn |
| Apr 4, 2021 | 70.19 Mn |
| Jan 3, 2021 | 19.13 Mn |